Department of Microbiology

Extramural

1. Isolation and Detection of Polio virus from stool Samples, National Polio Surveillance Project Duration 2019 - Continued Agency NPSP- WHO

2. National Centre for Disease Control (NCDC)-Establishment of surveillance network for influenza like illness (ILI) in the country Duration 2019 - Continued Agency NCDC

3. National Vector Borne Disease Control Programme (NVBDCP)- Apex Referral Laboratory by National Vector Borne Disease Control Programme (NVBDCP)" Duration 2019- Continued Agency National Vector Borne Disease Control Programme (NVBDCP)

4. HIV counselling and testing services: Integrated Counselling & Testing centre (ICTC) Duration 2019- Continued Agency Uttar Pradesh State AIDS Control Society (UPSACS)

5. Detection of Plasmodium falciparum and molecular epidemiology of drug resistance markers in a tertiary care centre” to Council of Science & Technology, Uttar Pradesh -UPCST (PI) Duration 2017-20 Agency Council of Science and Technology U.P.

6. Characterization of Human Microsporidium infection in patients with Immunocompromised status in northern India (PI) Duration 2010-12 Agency ICMR

7. Characterization of Human Cryptosporidium infection in patients with Immunocompromised status in northern India (PI) Duration 2008-10 Agency DBT, New Delhi

8. Role of Microsomal Epoxide Hydrolase Polymorphism in Gastric Cancer (PI) Duration 2008-09 Agency ICMR

9. Helicobacter pylori and gastric carcinogenesis: Role of glutathione and glutathione S transferase polymorphism (PI) Duration 2005-07 Agency DST, New Delhi

Intramural

1. Study to detect inflammatory biomarkers in gut and inflammatory response in serum in COVID-19 positive patients Duration 2020-2022 Agency SGPGI

2. A study on the prevalence, risk factors and molecular characterization of Clostridium difficile in patients with inflammatory bowel disease Duration 2017-20 Agency SGPGI

3. Detection and genetic characterization of Giardia lamblia Duration 2013-15 Agency SGPGI

4. Diagnosis of amoebic liver abscess; Comparative evaluation of antigen detection, antibody detection and polymerase chain reaction (PI) Duration 2007-08 Agency SGPGI

5. Helicobacter pylori and gastric carcinogenesis: Role of Cytochrome P-450 polymorphism (PI) Duration 2005-06 Agency SGPGI

1. Multicenter observational study on epidemiology, treatment and outcome of Mucormycosis in Funding Agency Fungal Infection Study Forum (FISF), India

2. Zygomycetes and mucormycosis: epidemiology, taxonomy and molecular biology. Funding Agency DBT

A retrospective surveillance of human fungal pathogens in Asia Funding Agency Asian Fungal Working Group (AFWG) and ISHAM

Phenotypic and Molecular Characterization of Fluoroquinolone Resistance in Salmonella species from Human Infections: a Pilot Study (completed)

Role of PCR in culture negative spontaneous bacterial peritonitis in children with liver disease: A prospective cohort study

NTEP: National tuberculosis elimination program

1.Characterization of epidemic plasmids, elucidation of evolutionary mechanism in carbapenem resistant Gram-negative bacteria and strategies to overcome carbapenem resistance ( Technically Approved).- ICMR

1.Phenotypic and Genotypic Characterization of Fosfomycin Resistance in Bacterial Isolates from Patients with Urinary Tract Infection: ( 2018-2020)

2. Detection of Gut Colonization by Carbapenemase Producing Gram Negative Bacteria and Their Molecular Characterization: ( 2018-2020)

1.Host genetic factors: association with peritonitis, co-morbidity and mortality in patients on continuous ambulatory peritoneal dialysis” – ICMR ( 2017-2020)

1. “Cytomegalovirus reactivation in critically ill immunocompetent patients with septic shock.

1. SERB- DBT funded Extramural project titled COVID-19: Patho physiology of severe manifestations of SARS-CoV-2 in patients with diabetes mellitus and long-term endocrine sequalae

2. ICMR funded Extramural project titled “Islet antibody negative type 1 diabetes in North India, clinical omplications and pathogenesis.”

3. ICMR funded Extramural project titled “To evaluate efficacy of Bacillus Calmette-Guerin (BCG) in Reducing the Incidence and severity of COVID-19 in the high-risk population (BRIC): a phase III, Multicentric, Quadruple blind Randomized controlled trial”.